Melanocortin receptor ligands

Details for Australian Patent Application No. 2002254744 (hide)

Owner The Procter & Gamble Company

Inventors Tian, Xinrong; Ebetino, Frank Hallock; Hu, Xiufeng Eric; Mazur, Adam Wieslaw

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002254744

PCT Pub. Number WO2002/085925

Priority 60/286,610 25.04.01 US

Filing date 24 April 2002

Wipo publication date 5 November 2002

Acceptance publication date 23 February 2006

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002254744

23 February 2006 Application Accepted

  Published as AU-B-2002254744

22 June 2006 Standard Patent Sealed

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002254745-METHOD, KIT AND DEVICE FOR THE TREATMENT OF COSMETIC SKIN CONDITIONS

2002254743-METHODS AND APPARATUS FOR FORMING AND CONTROLLING THE DIAMETER OF DRAWN OPTICAL GLASS FIBER